Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: A new entity in male infants

Blood

Volumn 117, Issue 21, 2011, Pages 5719-5722

  Quelen, Cathy ^a,b   Lippert, Eric ^c   Struski, Stephanie ^d   Demur, Cécile ^a,d   Soler, Gwendoline ^e   Prade, Nais ^a   Delabesse, Eric ^a,b,d   Broccardo, Cyril ^a   Dastugue, Nicole ^a,d   Mahon, François Xavier ^c   Brousset, Pierre ^a,b,d  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d CHU PURPAN   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; BASOPHIL; CASE REPORT; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC IDENTIFICATION; HUMAN; INFANT; MALE; MAST CELL LEUKEMIA; ONCOGENE MYB; PRIORITY JOURNAL; RARE DISEASE;

EID: 79957593470     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-333013     Document Type: Article

References (12)

1. Aquino VM. Acute myelogenous leukemia. Curr Probl Pediatr Adolesc Health Care. 2002;32(2):50-58. (Pubitemid 41128010)
2. Martens JH, Stunnenberg HG. The molecular signature of oncofusion proteins in acute myeloid leukemia. FEBS Lett. 2010;584(12):2662-2669.
3. Duchayne E, Demur C, Rubie H, Robert A, Dastugue N. Diagnosis of acute basophilic leukemia. Leuk Lymphoma. 1999;32(3-4):269-278. (Pubitemid 29087808)
4. Dastugue N, Duchayne E, Kuhlein E, et al. Acute basophilic leukaemia and translocation t(X;6)(p11; q23). Br J Haematol. 1997;98(1):170-176. (Pubitemid 27348812)
5. Chessells JM, Harrison CJ, Kempski H, et al. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia. 2002;16(5):776-784. (Pubitemid 34537548)
6. Belloni E, Shing D, Tapinassi C, et al. In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels. Leukemia. 2011;25(4):733-736.
7. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer. 2008;8(7):523-534. (Pubitemid 351881853)
8. Coyaud E, Struski S, Prade N, et al. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood;115(15):3089-3097.
9. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997;16(14):4226-4237. (Pubitemid 27298175)
10. Takahashi T, Suwabe N, Dai P, Yamamoto M, Ishii S, Nakano T. Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP. Oncogene. 2000;19(1):134-140. (Pubitemid 30066359)
11. Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda TJ, Ishii S. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci U SA. 1989;86(15):5758-5762. (Pubitemid 19217533)
12. Parker D, Rivera M, Zor T, et al. Role of secondary structure in discrimination between constitutive and inducible activators. Mol Cell Biol. 1999;19(8):5601-5607. (Pubitemid 29339917)